CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 186 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $182,000 | -14.2% | 15,000 | 0.0% | 0.09% | -19.8% |
| Q3 2019 | $212,000 | +26.9% | 15,000 | 0.0% | 0.12% | +30.3% |
| Q2 2019 | $167,000 | -5.1% | 15,000 | 0.0% | 0.09% | -5.3% |
| Q1 2019 | $176,000 | -12.0% | 15,000 | 0.0% | 0.09% | -23.0% |
| Q4 2018 | $200,000 | -4.8% | 15,000 | 0.0% | 0.12% | +8.0% |
| Q3 2018 | $210,000 | -11.0% | 15,000 | 0.0% | 0.11% | -15.7% |
| Q2 2018 | $236,000 | -4.5% | 15,000 | 0.0% | 0.13% | -15.7% |
| Q1 2018 | $247,000 | -8.9% | 15,000 | 0.0% | 0.16% | -7.0% |
| Q4 2017 | $271,000 | -6.6% | 15,000 | 0.0% | 0.17% | -8.6% |
| Q3 2017 | $290,000 | +63.8% | 15,000 | 0.0% | 0.19% | +55.8% |
| Q2 2017 | $177,000 | +142.5% | 15,000 | +50.0% | 0.12% | +110.5% |
| Q4 2016 | $73,000 | -71.9% | 10,000 | -75.0% | 0.06% | -72.1% |
| Q3 2016 | $260,000 | +19.3% | 40,000 | 0.0% | 0.20% | +16.6% |
| Q2 2016 | $218,000 | +16.6% | 40,000 | 0.0% | 0.18% | +17.4% |
| Q1 2016 | $187,000 | +21.4% | 40,000 | 0.0% | 0.15% | +10.4% |
| Q4 2015 | $154,000 | – | 40,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |